An open label follow-up, additional year study of bimatoprost ophthalmic solution 0.03% w/v in patients with glaucoma or ocular hypertension.
Phase of Trial: Phase III
Latest Information Update: 10 May 2017
At a glance
- Drugs Bimatoprost (Primary) ; Timolol
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- 10 May 2017 New trial record